We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EBIO: Epoch Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: shearson who wrote (20)11/4/2002 6:38:23 PM
From: tuck  Respond to of 33
I will be listening to this CC. I believe this past and next two quarters are vital to EBIO. They said in a recent PR that R. A. Welch of NCI would be presenting at two conferences in October, regarding the use of Eclipse probes in RT PCR for SNP analysis. The conference in Iceland doesn't publish the abstracts. The ASHG does, but I could find only one abstract by an R. welch. He seems to be with the NCI and is involved with SNPs, but the abstract makes only the vaguest reference to the assays, certainly nothing about Eclipse probes.

Can't find any reference to them on the NCI SNP pages, either. None of this has stopped EBIO from making an impressive bounce from the under a buck area during these two conferences, and I missed my chance to pick some cheap EBIO up by waiting for it to go under $.80 again.

After tomorrow, I will decide how much I want to chase it.

Cheers, Tuck